Ryuichi Noguchi Selected Research

Ryuichi Noguchi Research Topics

Disease

40	Liver Cirrhosis (Hepatic Cirrhosis) 01/2022 - 07/2002
24	Hepatocellular Carcinoma (Hepatoma) 01/2022 - 04/2002
22	Neoplasms (Cancer) 10/2020 - 04/2002
20	Fibrosis (Cirrhosis) 01/2022 - 07/2002
9	Fatty Liver 03/2020 - 10/2006
9	Carcinogenesis 03/2020 - 07/2002
8	Alcoholic Fatty Liver 02/2016 - 07/2008
7	Non-alcoholic Fatty Liver Disease 11/2021 - 10/2006
5	Liver Diseases (Liver Disease) 01/2020 - 01/2009
5	Insulin Resistance 08/2013 - 01/2009
4	Chronic Hepatitis C 12/2014 - 02/2005
3	Infections 03/2022 - 05/2013
3	Acute Liver Failure (Fulminant Hepatic Failure) 03/2011 - 07/2006
2	Pleural Effusion (Pleural Effusions) 03/2022 - 08/2017
2	Ascites 03/2022 - 08/2017
2	Chronic Hepatitis B 08/2020 - 09/2017
2	Hepatitis C 01/2018 - 08/2017
2	Type 2 Diabetes Mellitus (MODY) 11/2017 - 02/2016
2	Obesity 08/2013 - 01/2009
2	Inflammation (Inflammations) 01/2013 - 05/2012
2	Eosinophilia 05/2012 - 07/2007
1	Gallstones (Gallstone) 04/2023
1	End Stage Liver Disease 08/2022
1	Hypoalbuminemia 03/2022
1	Biliary Liver Cirrhosis (Primary Biliary Cirrhosis) 03/2022
1	Edema (Dropsy) 03/2022
1	Duodenal Ulcer (Curling's Ulcer) 01/2021

Drug/Important Bio-Agent (IBA)

19	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 10/2019 - 04/2002
19	Angiotensin-Converting Enzyme Inhibitors (ACE Inhibitors)IBA 01/2012 - 06/2002
13	Amino Acids FDA Link 03/2020 - 07/2002
12	Choline (Choline Chloride)IBA 03/2020 - 07/2002
11	InterferonsIBA 09/2018 - 02/2005
9	CDAA (Randox)IBA 11/2017 - 07/2002
9	Angiogenesis Inducing Agents (Angiogenesis Factor)IBA 08/2010 - 12/2003
8	Angiotensin IIIBA 11/2017 - 09/2003
8	Perindopril FDA LinkGeneric 11/2006 - 06/2002
7	CollagenIBA 10/2020 - 07/2002
6	Biomarkers (Surrogate Marker)IBA 08/2022 - 07/2003
6	Angiotensin II Type 1 Receptor BlockersIBA 01/2022 - 05/2009
6	Glutathione Transferase (Glutathione S-Transferase)IBA 11/2013 - 07/2003
5	Losartan (Cozaar)FDA LinkGeneric 01/2022 - 05/2009
5	Messenger RNA (mRNA)IBA 11/2017 - 04/2002
5	Branched-Chain Amino AcidsIBA 08/2013 - 01/2009
4	Aspartate Aminotransferases (Aspartate Transaminase)IBA 10/2021 - 09/2017
4	AldosteroneIBA 08/2017 - 05/2010
4	Transforming Growth Factor beta (TGF-beta)IBA 12/2016 - 05/2006
4	EnzymesIBA 11/2013 - 07/2002
4	Vitamin K FDA Link 05/2011 - 01/2007
4	Imatinib Mesylate (Gleevec)FDA Link 04/2009 - 05/2005
3	Carrier Proteins (Binding Protein)IBA 10/2021 - 09/2017
3	CytokinesIBA 01/2013 - 05/2006
3	Chelating AgentsIBA 06/2011 - 09/2003
3	Vitamin K 2 (Vitamin K2)IBA 08/2009 - 01/2006
3	Hydroxyproline (4 Hydroxyproline)IBA 05/2005 - 07/2002
3	Tissue Inhibitor of Metalloproteinase-1IBA 09/2003 - 10/2002
2	Proteins (Proteins, Gene)FDA Link 03/2022 - 11/2007
2	SteroidsIBA 03/2022 - 05/2012
2	Hyaluronic Acid (Hyaluronan)IBA 10/2021 - 08/2020
2	Collagen Type IV (Type IV Collagen)IBA 10/2021 - 02/2016
2	Tissue Inhibitor of MetalloproteinasesIBA 10/2021 - 08/2020
2	Collagen Type III (Type III Collagen)IBA 10/2021 - 08/2020
2	Antiviral Agents (Antivirals)IBA 08/2020 - 01/2018
2	Glucose (Dextrose)FDA LinkGeneric 03/2020 - 11/2017
2	Therapeutic UsesIBA 11/2017 - 01/2008
2	Dipeptidyl-Peptidase IV InhibitorsIBA 11/2017 - 02/2016
2	Peptidyl-Dipeptidase A (Angiotensin Converting Enzyme)IBA 09/2017 - 06/2002
2	Alanine Transaminase (SGPT)IBA 09/2017 - 11/2006
2	ReninIBA 08/2017 - 11/2013
2	Anti-Bacterial Agents (Antibiotics)IBA 03/2015 - 05/2013
2	EndotoxinsIBA 03/2015 - 01/2013
2	Ribavirin (Virazole)FDA LinkGeneric 12/2014 - 07/2011
2	Angiotensin Receptor AntagonistsIBA 10/2014 - 07/2011
2	Sorafenib (BAY 43-9006)FDA Link 10/2014 - 05/2012
2	Transforming Growth Factors (Transforming Growth Factor)IBA 03/2014 - 01/2012
2	Angiogenesis InhibitorsIBA 05/2011 - 02/2007
2	Vascular Endothelial Growth Factor Receptors (VEGF Receptors)IBA 08/2010 - 05/2005
2	Tumor Biomarkers (Tumor Markers)IBA 01/2009 - 06/2007
2	Diethylnitrosamine (N-Nitrosodiethylamine)IBA 12/2008 - 07/2002
2	CopperIBA 07/2005 - 09/2003
2	Trientine (Trien)FDA Link 07/2005 - 09/2003
2	Protein Kinase CIBA 05/2005 - 09/2003
2	Interferon-betaIBA 02/2005 - 12/2003
2	Matrix Metalloproteinases (MMPs)IBA 06/2003 - 10/2002
1	Blood Proteins (Serum Proteins)IBA 03/2022
1	Azathioprine (Imuran)FDA LinkGeneric 03/2022
1	Immunosuppressive Agents (Immunosuppressants)IBA 03/2022
1	LipopolysaccharidesIBA 01/2022
1	obeticholic acidIBA 01/2022
1	Toll-Like Receptor 4IBA 01/2022
1	SE5-OHIBA 11/2021
1	nasIBA 11/2021
1	EquolIBA 11/2021
1	Peptides (Polypeptides)IBA 10/2021
1	olmesartanIBA 01/2021
1	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 10/2020
1	5- chloro- 2- (((2- (4- (diphenylmethyl)piperazin- 1- yl)- 2- oxoethoxy)acetyl)amino)benzoateIBA 10/2020

Therapy/Procedure

19	Therapeutics 03/2022 - 11/2004
6	Chemoprevention 10/2014 - 11/2004
1	Endoscopes 04/2023
1	Radiofrequency Ablation 01/2022